Iclusig 15 mg film-coated tablets, BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion., Imatinib TAD 400 mg επικαλυμμένα με λεπτό υμένιο δισκία
SPON - 1751-19
Phase 2 small_molecule active
Quick answer
Iclusig 15 mg film-coated tablets, BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion., Imatinib TAD 400 mg επικαλυμμένα με λεπτό υμένιο δισκία for Blood cancer is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Blood cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active